Announce initial safety data from cohort 1 of Phase 1 study for KB301
Delivered by the deadline
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 7 Jan 2021
- Due
- 31 Mar 2021
- Delivered
- 24 Mar 2021
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“1Q21 KB301 for aesthetic indications Announce Initial safety data from cohort 1 of Phase 1 study in facial wrinkles and acne scars”
What we found
Evidence strength A What the grades mean
The company announced initial safety and tolerability data from Cohort 1 of the Phase 1 study for KB301 on March 24, 2021, which is within the first quarter of 2021.
-
A Krystal Biotech, Inc. 10-Q filed 2021-05-10
“On March 24, 2021 we announced initial data from Cohort 1 of the Phase 1 study that showed safety and tolerability of two (2) repeat KB301 injections in human subjects.” ✓ confirmed on the page
Market reaction: the shares moved -7.4% against the S&P 500 over the three sessions around the disclosure (7 May 2021 to 12 May 2021). What this measures
Checked 24 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Clinical readout
- Indicative materiality
- Medium rules
- Action
- Announce
- Deliverable
- Phase 1 cohort 1 safety data
- In the company’s control
- High
- Specificity
- High
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you Krystal Biotech, Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2021-KRYS-021263 · Corrections policy